Skip to main content

Stefan Teipel

About

Country
Germany
Position
Member

Stefan Teipel is a full professor and specialist in psychiatry and psychotherapy at the Clinic for Psychosomatic Medicine and Psychotherapy and head of the Section for Clinical Dementia Research at the University Medical Center Rostock (since 2013). He is also deputy speaker of the German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald (since 2009).

His research focuses on the development of diagnostic and treatment approaches for neurodegenerative dementias from experimental to health care settings, as well as the development and implementation of digital assistive devices for people with dementia.  The active involvement of people with dementia and their caregivers in research using participatory research methods has become an increasing focus in recent years. Stefan Teipel has received national and European research funding, and is advisory board member in national and international projects, including the Independent Data Monitoring Committee for ENVISION 221AD305 Study (Biogen), Member of the Department Individual and Societal Aging of the Interdisciplinary Faculty, University of Rostock, Co-Head of the Neuroimaging Section of the German Society of Biological Psychiatry, and Advisory Board Member of the Alzheimer Forschung Initiative (AFI) e. V., and Senior Associate Editor of Alzheimer’s & Dementia DADM.

Declaration of Interests

Strategic Advisory Roles

 

Duration Company Position/Meeting
05/2022 – ongoing Biogen MA Inc. Consultant Data Safety Monitoring Board
02/2022 – 02/2022 Biogen GmbH Consultant Advisory Board “Antibodies from an interdisciplinary perspective”
01/2022 – 01/2022 Roche Pharma AG Consultant Advisory Board
12/2021 – 12/2021 Biogen GmbH Consultant 2nd Brain Trust Meeting
11/2021 – 11/2021 Eisai Inc. Consultant Eisai Global Medical Affairs Advisory Board
11/2021 – 11/2021 Biogen GmbH Consultant Alzheimer Round Table Mecklenburg-Western Pomerania
09/2021 – 09/2021 Roche Pharma AG Consultant Alzheimer Medical Advisory Board
07/2021 – 07/2021 Biogen GmbH Consultant Brain Trust Kick off Meeting
05/2021 – 05/2021 Biogen GmbH Consultant Advisory Board
04/2021 – 04/2021 Grifols Deutschland GmbH Consultant German Alzheimer’s disease Expert Panel
03/2021 – 03/2021 Roche Pharma AG Consultant National Alzheimer Advisory Board
01/2021 – 01/2021 Dr. Willmar Schwabe GmbH & Co. KG Speaker Lecture at the online Expert Discussion “MCI”
09/2020 – 09/2020 Biogen GmbH Consultant AD Board MCI-Ad Case Finding in Primary Care
04/2020 – 04/2020 Biogen GmbH Consultant Virtual Alzheimer Advisory Session I
04/2020 – 04/2020 Biogen GmbH Consultant
Virtual AAT-AD PD Focus Meeting
02/2020 – 02/2020 Philips GmbH
Market DACH
Speaker
Symposium “Update Dementias”
09/2019 – 09/2019 Roche Pharma AG Consultant
Advisory Board
09/2019 – 09/2019 Roche Pharma AG Speaker
Roche Symposium “DNG”
08/2019 – 08/2019 MSD Sharp & Dohme GmbH Speaker
Symposium “Diabetes and Dementia”

 

Financial Interests

Date Company Role
04/2023 – 04/2023 EISAI GmbH Honorarium for oral presentation at Auguste Symposium in Berlin, 22.04.2023

 

 

Date Company Product Name Therapeutic Indication (Country)
04/2021 – ongoing Roche Pharma AG Gantenerumab Alzheimer Disease (Germany)
08/2019 – 12/2022 Boehringer Ingelheim Pharma GmbH & Co. KG Methodological Study: Development of a software application for speech analysis in patients with AD N/A
10/2018 – ongoing Roche Pharma AG Gantenerumab Alzheimer Disease (Germany)
01/2017 – 12/2019 Piramal Imaging Ltd. NeuraCeqTM Amyloid PET Diagnostic (UK)
11/2014 – 12/2019 H. Lundbeck A/S Lu AE58054 Alzheimer Disease (Denmark)

 

Investigator

Duration Company Product Name Therapeutic Indication
11/2019 – ongoing Fujifilm Toyama Chemical Ltd, NL T-817MA Alzheimer Disease